- Advertisement -
Wednesday, September 23, 2020
32.7 C
Delhi
Home Latest News RAM TEMPLE ‘BHOOMI PUJAN’: PM NARENDRA MODI TO BE PRESENTED WITH LORD...

RAM TEMPLE ‘BHOOMI PUJAN’: PM NARENDRA MODI TO BE PRESENTED WITH LORD RAM IDOL

Construction of the grand temple of Ram Temple will begin with ‘Bhoomi Pujan’ in Ayodhya. After the puja ceremony, a special present will be offered to PM Modi by the Shri Ram Janmabhoomi Teertha Kshetra Trust. 

Image Courtesy Zee News

AYODHYA: Prime Minister Narendra Modi will on Wednesday (August 5) attend a public function on laying of the foundation stone of ‘Shree Ram Janmabhoomi Mandir’ in Ayodhya, the Prime Minister’s Office said.

Prior to the function, the prime minister will take part in a ‘pooja’ and ‘darshan’ at Hanumangarhi, a statement by the PMO said. 

Construction of the grand temple of Ram Temple will begin with ‘Bhoomi Pujan’ in Ayodhya. After the puja ceremony, a special present will be offered to PM Modi by the Shri Ram Janmabhoomi Teertha Kshetra Trust. 

Temple Trust Mahant Nritya Gopaldas will present a special idol of Lord Ram, prepared in Aligarh with octo-alloy, to PM Modi.  According to sources, souvenirs have been presented to the Temple Trust but consent from the administration is still awaited. Once approval is given to it, these idols will be allowed to be taken to the place of worship.

A silver coin will be presented as a ‘Prasad’ to every guest invited to the ‘Bhoomi Pujan’ ceremony for the construction of a grand Ram temple in Ayodhya. On one side of the silver coin is the image of Rama Darbar which has Lord Rama, Sita, Lakshmana and Hanuman; while the other side has the symbol of trust.

The guests at Ram Temple ‘Bhoomi Pujan’ will also be given a ‘Laddu’ box and a picture of Ram Darbar.

According to sources, more than 1.25 lakh laddus, which have been named as’Raghupati Laddus’, will be distributed among the residents of Ayodhya on August 5. 

News Credit Zee News

- Advertisement -

Subscribe to our newsletter

To be updated with all the latest news,

- Advertisement -

Stay Connected

8,000FansLike
2,458FollowersFollow
61,453SubscribersSubscribe

Must Read

NCB SUMMONS DEEPIKA PADUKONE, SHRADDHA KAPOOR, SARA ALI KHAN, RAKUL PREET SINGH IN DRUGS CASE

Today, the NCB probed Sushant’s former manager and KWAN employee Jaya Saha, director of the management agency, producer Madhu Mantena. 
- Advertisement -

US, UAE EYE DECEMBER GOAL TO AGREE ON F-35 DEAL, SAY SOURCES

Sources close to the negotiations said the goal is to have a letter of agreement in place in time for UAE National...

IMD PREDICTS VERY HEAVY RAINFALL IN WEST BENGAL, ASSAM, UTTAR PRADESH AND BIHAR OVER NEXT FEW DAYS

A low-pressure area lies over central parts of west Madhya Pradesh and neighbourhood with associated cyclonic circulation extending up to mid-tropospheric levels.

CORONAVIRUS CAME FROM A LAB ON PURPOSE, SAYS CHINESE VIROLOGIST DR LI-MENG YAN

On being asked whether she thought that the Chinese government could influence studies and research on COVID-19, Dr Li-Meng Yan said “Of...

Related News

NCB SUMMONS DEEPIKA PADUKONE, SHRADDHA KAPOOR, SARA ALI KHAN, RAKUL PREET SINGH IN DRUGS CASE

Today, the NCB probed Sushant’s former manager and KWAN employee Jaya Saha, director of the management agency, producer Madhu Mantena. 

US, UAE EYE DECEMBER GOAL TO AGREE ON F-35 DEAL, SAY SOURCES

Sources close to the negotiations said the goal is to have a letter of agreement in place in time for UAE National...

IMD PREDICTS VERY HEAVY RAINFALL IN WEST BENGAL, ASSAM, UTTAR PRADESH AND BIHAR OVER NEXT FEW DAYS

A low-pressure area lies over central parts of west Madhya Pradesh and neighbourhood with associated cyclonic circulation extending up to mid-tropospheric levels.

CORONAVIRUS CAME FROM A LAB ON PURPOSE, SAYS CHINESE VIROLOGIST DR LI-MENG YAN

On being asked whether she thought that the Chinese government could influence studies and research on COVID-19, Dr Li-Meng Yan said “Of...

RUSSIA TO REGISTER SECOND CORONAVIRUS VACCINE BY OCTOBER 15

The vaccine has been developed by Siberia’s Vector Institute, which completed early-stage human trials of the vaccine last week.
- Advertisement -